Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AGALSIDASE BETA for Complement deficiency disease: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where AGALSIDASE BETA was used for Complement deficiency disease.

Most Reported Side Effects for AGALSIDASE BETA

Side Effect Reports % Deaths Hosp.
Malaise 409 6.4% 15 113
Pain 395 6.2% 7 109
Pyrexia 362 5.7% 8 106
Fatigue 338 5.3% 11 82
Nausea 303 4.8% 1 68
Weight decreased 272 4.3% 6 71
Headache 269 4.2% 3 58
Dyspnoea 266 4.2% 18 105
Chills 259 4.1% 2 44
Vomiting 244 3.8% 5 73
Pain in extremity 235 3.7% 5 65
Weight increased 228 3.6% 1 32
Cough 200 3.1% 2 25
Infusion related reaction 195 3.1% 2 23
Dizziness 193 3.0% 4 66

Other Indications for AGALSIDASE BETA

Fabry's disease (4,670) Lipidosis (289) Product used for unknown indication (107) Gaucher's disease (14) Renal transplant (13) Mucopolysaccharidosis (8) Lipid metabolism disorder (6) Proteinuria (5)

Other Drugs Used for Complement deficiency disease

ICATIBANT (338) HUMAN C1-ESTERASE INHIBITOR (59) HUMAN IMMUNOGLOBULIN G (8) ALPHA.1-PROTEINASE INHIBITOR HUMAN (5)

Related Pages

AGALSIDASE BETA Full Profile All Complement deficiency disease Drugs AGALSIDASE BETA Demographics AGALSIDASE BETA Timeline